Metformin and Colorectal Cancer Risk in Diabetic Patients

被引：14
|
作者：
Ioannou, George N. [1 ,2 ,3 ]
Boyko, Edward J. [2 ,3 ,4 ]
机构：
[1] Vet Affairs Puget Sound Hlth Care Syst, Div Gastroenterol, Dept Med, Seattle, WA USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Vet Affaiis Puget Sound Hlth Care Syst, Res Enhancement Award Program, Seattle, WA USA
[4] Vet Affairs Puget Sound Hlth Care Syst, Div Internal Med, Dept Med, Seattle, WA USA
来源：
DIABETES CARE | 2011年 / 34卷 / 10期
关键词：
BREAST-CANCER; EUROPEAN ASSOCIATION; CONSENSUS ALGORITHM; MEDICAL-MANAGEMENT; METABOLIC SYNDROME; TYPE-2; THERAPY; HYPERGLYCEMIA; METAANALYSIS; ADJUSTMENT;
D O I：
10.2337/dc11-1447
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2336 / 2337
页数：2
相关论文
共 50 条
  • [1] Metformin and reduced risk of cancer in diabetic patients
    Evans, JMM
    Donnelly, LA
    Emslie-Smith, AM
    Alessi, DR
    Morris, AD
    BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7503): : 1304 - 1305
  • [2] The Effects of Metformin on Survival After Diagnosis of Colorectal Cancer in Diabetic Patients
    Lee, Jin Ila
    Kim, Tae Il
    Jeon, Soung Min
    Hong, Sung Pil
    Cheon, Jae Ilce
    Kim, Won Ito
    GASTROENTEROLOGY, 2011, 140 (05) : S681 - S681
  • [3] Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer
    Lee, Jin Ha
    Jeon, Soung Min
    Hong, Sung Pil
    Cheon, Jae Hee
    Kim, Tae Il
    Kim, Won Ho
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (12) : 1042 - 1047
  • [4] Identifying Predictive Biomarkers of Outcome in Diabetic Colorectal Cancer Patients Treated with Metformin
    Orr, Christine
    Nicol, Christopher
    Feilotter, Harriet
    Biagi, Jim
    Hammad, Nazik
    Mulligan, Lois
    O'Callaghan, Chris
    Ramjeesingh, Ravi
    Ren, Kevin
    Song, Kevin
    Virik, Kiran
    Wang, Ami
    Davey, Scott
    Hurlbut, David
    MODERN PATHOLOGY, 2019, 32
  • [5] Effects of Metformin on CD133+Colorectal Cancer Cells in Diabetic Patients
    Zhang, Yanfei
    Guan, Meiping
    Zheng, Zongji
    Zhang, Qian
    Gao, Fang
    Xue, Yaoming
    PLOS ONE, 2013, 8 (11):
  • [6] Identifying Predictive Biomarkers of Outcome in Diabetic Colorectal Cancer Patients Treated with Metformin
    Orr, Christine
    Nicol, Christopher
    Feilotter, Harriet
    Biagi, Jim
    Hammad, Nazik
    Mulligan, Lois
    O'Callaghan, Chris
    Ramjeesingh, Ravi
    Ren, Kevin
    Song, Kevin
    Virik, Kiran
    Wang, Ami
    Davey, Scott
    Hurlbut, David
    LABORATORY INVESTIGATION, 2019, 99
  • [7] Metformin may lower the risk of colorectal adenoma in diabetic patients: a meta-analysis
    Zhong, Hao-Jie
    Chen, Yu
    He, Xing-Xiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (10): : 19682 - 19690
  • [8] Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients
    Jung Won Park
    Jin Ha Lee
    Ye Hyun Park
    Soo Jung Park
    Jae Hee Cheon
    Won Ho Kim
    Tae Il Kim
    World Journal of Gastroenterology, 2017, (28) : 5196 - 5205
  • [9] Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients
    Park, Jung Won
    Lee, Jin Ha
    Park, Ye Hyun
    Park, Soo Jung
    Cheon, Jae Hee
    Kim, Won Ho
    Kim, Tae Il
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (28) : 5196 - 5205
  • [10] Gender-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients
    Park, Jung Won
    Kim, Sung Bae
    Lee, Jin Ha
    Lee, Hyun Jung
    Park, Soo Jung
    Hong, Sung Pil
    Cheon, Jae Hee
    Kim, Won Ho
    Kim, Tae Ii
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 99 - 100
12345